Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2007
06/28/2007US20070149475 AUGMENTATION OF WOUND HEALING BY eIF-4E mRNA AND EGF mRNA
06/28/2007US20070149473 RNAi-mediated inhibition of RHO kinase for treatment of ocular disorders
06/28/2007US20070149471 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer
06/28/2007US20070149470 Inhibition of viral gene expression using small interfering RNA
06/28/2007US20070149468 Methods and compositions for rna interference
06/28/2007US20070149467 vascular endothelial growth factor (VEGF); ischemic heart disease
06/28/2007US20070149455 Modified and stabilized gdf propeptides and uses thereof
06/28/2007US20070149408 Applying an aqueous solution of a ferulic acid compound on a whole tobacco leaf prior to curing; and curing said whole tobacco leaf; or apply the solution on the whole tobacco leaf between immediately before to immediately after harvesting of the tobacco plant, but prior to curing; detoxification
06/28/2007US20070148776 Method capable of increasing competency of bacterial cell transformation
06/28/2007US20070148775 Method for cloning and expressing target gene by homologous recombination
06/28/2007US20070148774 Methods for producing members of specific binding pairs
06/28/2007US20070148773 Sequence specific dna recombination in eukaryotic cells
06/28/2007US20070148765 Preservative-containing virus formulations
06/28/2007US20070148758 Electrofusion microelectrode
06/28/2007US20070148757 Electrofusion microelectrode and methods of using it to manipulate cells and/or cellular components
06/28/2007US20070148752 Polypeptide which can degrade galactose bonds; hybridization; useful in sugar chain engineering reagents and analyzing polysaccharide structure
06/28/2007US20070148749 Process for producting 1,3-propanediol and or/3-hydroxypropionic acid
06/28/2007US20070148748 Fermentation process using specific oxygen uptake rates as a process control
06/28/2007US20070148747 Genes involved in polyketide synthase pathways and uses thereof
06/28/2007US20070148742 Racemization and deprotection of special N-protected amino acids in the acylase/racemase system for the total conversion of special N-protected racemic amino acids into optically pure amino acids
06/28/2007US20070148739 amino acid substitutions at specific positions that confer increased relative activity in biological assays with reduced immunogenic potential in the protein; hepatitis C virus infection
06/28/2007US20070148737 Materials and Methods For the Purification of Polyelectrolytes, Particularly Nucleic Acids
06/28/2007US20070148735 Novel chromophores/fluorophores and methods for using the same
06/28/2007US20070148734 Hyaluronic acid mediated adenoviral transduction
06/28/2007US20070148733 Yeast expression vectors for production of ITF
06/28/2007US20070148732 Novel enzymes
06/28/2007US20070148731 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator
06/28/2007US20070148730 Superactive cellulase formulation using cellobiohydrolase-1 from penicillium funiculosum
06/28/2007US20070148729 Methods for increasing neisseria protein expression and compositions thereof
06/28/2007US20070148727 make it possible to produce rare carotenoids in which a hydroxyl group is introduced at the position 2(2') carbon in their beta -ionone ring in large quantities
06/28/2007US20070148715 Method for detecting transient ligand interactions
06/28/2007US20070148706 Pancreatic progenitor cells and methods for isolating the same
06/28/2007US20070148693 Circular recombinant plasmid dna constructs and their protein products, methods of preparation and immobilisation of proteins on support
06/28/2007US20070148692 KCNQ potassium channels and methods of modulating same
06/28/2007US20070148688 Novel human enzymes of the metalloprotease family
06/28/2007US20070148687 For analyzing nucleic acid replication; polymerase/ligase chain reactions
06/28/2007US20070148686 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof
06/28/2007US20070148682 Protein fragment complementation assays for the detection of biological or drug interactions
06/28/2007US20070148680 Detection of disease related genes
06/28/2007US20070148671 DNA polymerase fusions and uses thereof
06/28/2007US20070148654 Supressing spreading or bleeding of a probe solution on a substrate and fix DNA probes, a biochip with probe regions arranged at a high density can be manufactured easily
06/28/2007US20070148653 Fine metal structure, process for producing the same, fine metal mold and device
06/28/2007US20070148651 Method and kit for the isolation of rna
06/28/2007US20070148642 Method for detecting gene specifying allergic predisposition
06/28/2007US20070148636 Method, compositions and kits for preparation of nucleic acids
06/28/2007US20070148629 Composition for the preservation of viruses
06/28/2007US20070148246 Nucleic Acid-Based Matrixes
06/28/2007US20070148179 Gankyrin
06/28/2007US20070148174 Admixing with monoclonal antibodies; binds to ribonuclease; DNA or RNA maintains its intact, full-length form during production and storage
06/28/2007US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6
06/28/2007US20070148166 Scfvs in photosynthetic microbes
06/28/2007US20070148158 Rationally designed heparinases derived from heparinase II
06/28/2007US20070148156 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
06/28/2007US20070148143 Human cytokine receptor
06/28/2007US20070148132 Nervous system disorder; includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system; tightly regulatable gene delivery vector
06/28/2007US20070148093 Non-terminal method of identifying anti-migraine compounds
06/28/2007CA2833029A1 Treatment of cellulosic material and enzymes useful therein
06/28/2007CA2638818A1 Enhancement of carotenoids in plants
06/28/2007CA2634898A1 Immunogenic composition
06/28/2007CA2634824A1 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
06/28/2007CA2634624A1 Polypeptide targeting to mitochondria
06/28/2007CA2634291A1 Transcription factor decoy oligodeoxynucleotides having multiple cis elements
06/28/2007CA2634116A1 Anti-ilt7 antibody
06/28/2007CA2633793A1 Methods of clustering gene and protein sequences
06/28/2007CA2633790A1 Methods and compositions for the detection and isolation of ligands
06/28/2007CA2633776A1 Immuno-rna-constructs
06/28/2007CA2633756A1 Pharmaceutical antibody compositions with resistance to soluble cea
06/28/2007CA2633741A1 Improved targeted nucleotide exchange with propynyl modified oligonucleotides
06/28/2007CA2633713A1 Epha2 bite molecules and uses thereof
06/28/2007CA2633640A1 Improved targeted nucleotide exchange with lna modified oligonucleotides
06/28/2007CA2633456A1 Chemical induction of quiescence in bacteria using indole compounds
06/28/2007CA2633346A1 Dna vaccine for cancer therapy
06/28/2007CA2633213A1 Soluble gp130 molecule variants useful as a medicament
06/28/2007CA2633138A1 Methods for generating and screening fusion protein libraries and uses thereof
06/28/2007CA2633131A1 Novel cancer-associated antigen
06/28/2007CA2632502A1 Treatment of cellulosic material and enzymes useful therein
06/28/2007CA2632435A1 Soluble il-17rc variant and uses thereof
06/28/2007CA2631236A1 Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
06/28/2007CA2630416A1 Mitigation of cot-1 dna distortion in nucleic acid hybridization
06/28/2007CA2626763A1 Method for producing 5-norbornen-2-carboxylic acid from 5-norbornen-2-carbonitrile using an arylacetonitrilase
06/27/2007EP1801240A1 Methods and compositions for assessment of pulmonary function and disorders
06/27/2007EP1801236A2 Endometriosis related markers and uses thereof
06/27/2007EP1801230A1 Method of selecting protein easily undergoing antigen-presentation by dentritic cells
06/27/2007EP1801223A2 Rice promoters
06/27/2007EP1801222A1 Parthenocarpic tomatoes and production method thereof
06/27/2007EP1801221A1 Promoter sequences
06/27/2007EP1801220A2 Insect-resistant transgenic plants and methods for improving delta-endotoxin activity against insects
06/27/2007EP1801219A2 Neisserial antigenic peptides
06/27/2007EP1801218A2 Nucleic acids and proteins from streptococcus pneumoniae
06/27/2007EP1801217A1 Group A streptococcal vaccines
06/27/2007EP1801216A2 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
06/27/2007EP1801215A2 Regulation of viral gene expression
06/27/2007EP1801214A2 In vitro sorting method
06/27/2007EP1801213A2 Polymerase
06/27/2007EP1801212A1 Selection of biocatalysts for chemical synthesis
06/27/2007EP1801211A1 Hla-binding peptide, dna fragment encoding the same and recombinant vector
06/27/2007EP1801210A1 Conjugate of peo with double-stranded nucleic acid
06/27/2007EP1801209A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence
06/27/2007EP1801208A1 Anti-a33 antibody
06/27/2007EP1801207A1 Method of detecting intracellular micronucleus